Clinical Trial Update: Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating pet imaging as a biomarker in hormone-refractory postmenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED